LATEST WEBINARS
Live date: Tuesday 11 June 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Quantitative, sensitive and specific bioanalytical methods for the investigation of therapeutic oligonucleotides in biological matrices
Live date: Wednesday 29 May 2019 10:00 [EDT] 15:00 [BST] 22:00 [HKT]. This webinar will detail strategies for improving recovery, sensitivity and repeatability in challenging peptide bioanalytical workflows, while maximizing the utilization of small sample size.
Webinar available to view on demand. Arno Kromminga and Lydia Michaut will discuss the strategies and challenges of immunogenicity assessment for gene therapy compounds.
In this free on demand panel discussion, our experts provide insights into their own research with cellular and gene therapies including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
The speakers from our January panel discussion on immunogenicity answer further questions from the live event
We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on FDA guidance, transitioning skills and future hopes for the bio lab.
Webinar available to view on demand. In this case study, Alturas Analytics (ID, USA) presents the techniques they use in their labs for optimal analysis of large molecules from biological matrices.
Thank you everyone who attended our live webinar ‘Clinical relevance of (unwanted drug induced) immune responses’. Here are some responses to the questions posed during the live event that we did not have time to answer.
Latest News
Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Latest Features
In this editorial, Reiner Schulte (Cambridge Institute for Medical Research, UK) discusses the market of flow cytometry analyzers and cell sorters, highlighting some interesting developments in the field of flow cytometry.
Complete our short survey on flow cytometry and be the first to receive our informative infographic collated from the survey results.
Find out more about the role of exosomes in flow cytometry studies and future pharmacological developments in this interview with Joyce Slusser (KCAS; KS, USA).
Drug Discovery and Development
Drug detection in biological specimens: recent colorimetric methods
Signal amplification technology reveals previously undetectable proteins of disease
Bioanalytical laboratory considerations for immuno-oncology drug development
Ligand-binding
Biotherapeutic characterization and quantification: an interview with Pegah Jalili
Hybrid assays: the next big thing?
Evolution of fit-for-purpose biomarker validations: an LBA perspective
Mass Spectrometry
Signal amplification technology reveals previously undetectable proteins of disease
An author’s perspective: Laura Rowe on analyzing protein glycosylation using UHPLC
Sample preparation, extraction & collection
In the Zone: alternative matrices
Noninvasive method potentially as effective at measuring blood glucose as finger prick test
Nanopore system offers real-time single molecule analysis of complex biological samples